You are here
Samsung Bioepis races to get biosimilar drugs on the market
AS Samsung Bioepis raced to be first to market with a copy of Enbrel, a blockbuster rheumatoid arthritis drug, countdown clocks reminded workers: heading for lunch, meetings or even the washroom: of the days to the first mass production run.
Founded four years ago by South
CALL +65 6388 3838 EMAIL firstname.lastname@example.org